Loading...
Docoh

Incyte (INCY)

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics.

Company profile

Ticker
INCY
Exchange
Website
CEO
Herve Hoppenot
Employees
Incorporated
Location
Fiscal year end
Former names
INCYTE GENOMICS INC, INCYTE INC, INCYTE PHARMACEUTICALS INC
SEC CIK
Subsidiaries
Incyte Biosciences Corporation • Incyte Holdings Corporation • Incyte Research Institute LLC • Incyte International Holdings Corporation • Incyte Biosciences Canada Corporation • Incyte International Holdings • Incyte Biosciences International • Incyte Biosciences Austria GmbH • Incyte Biosciences Denmark ApS • Incyte Biosciences Germany GmbH ...
IRS number
943136539

INCY stock data

Analyst ratings and price targets

Last 3 months

Calendar

3 May 22
26 Jun 22
31 Dec 22
Quarter (USD) Mar 22 Dec 21 Sep 21 Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
15 Jun 22 Otis W Brawley Common Stock Grant Acquire A No No 0 2,144 0 3,399
15 Jun 22 Otis W Brawley NQSO Common Stock Grant Acquire A No No 68.55 9,124 625.45K 9,124
15 Jun 22 Fouse Jacqualyn A Common Stock Grant Acquire A No No 0 2,144 0 10,655
15 Jun 22 Fouse Jacqualyn A NQSO Common Stock Grant Acquire A No No 68.55 9,124 625.45K 9,124
15 Jun 22 Clancy Paul J Common Stock Grant Acquire A No No 0 2,144 0 10,434
15 Jun 22 Clancy Paul J NQSO Common Stock Grant Acquire A No No 68.55 9,124 625.45K 9,124
15 Jun 22 Harrigan Edmund Common Stock Grant Acquire A No No 0 2,144 0 7,716
15 Jun 22 Harrigan Edmund NQSO Common Stock Grant Acquire A No No 68.55 9,124 625.45K 9,124
15 Jun 22 Jean Jacques Bienaime Common Stock Grant Acquire A No No 0 2,144 0 12,988
15 Jun 22 Jean Jacques Bienaime NQSO Common Stock Grant Acquire A No No 68.55 9,124 625.45K 9,124
13F holders Current Prev Q Change
Total holders 512 517 -1.0%
Opened positions 65 91 -28.6%
Closed positions 70 56 +25.0%
Increased positions 184 196 -6.1%
Reduced positions 187 163 +14.7%
13F shares Current Prev Q Change
Total value 22.78B 21.11B +7.9%
Total shares 238.32M 236.53M +0.8%
Total puts 778K 1.29M -39.7%
Total calls 547.5K 758.64K -27.8%
Total put/call ratio 1.4 1.7 -16.5%
Largest owners Shares Value Change
Baker Bros. Advisors 36.15M $2.87B +7.5%
Baker Julian 34.28M $4.13B 0.0%
Vanguard 20.89M $1.66B -0.3%
BLK Blackrock 18.09M $1.44B -1.3%
Dodge & Cox 18.06M $1.43B +8.4%
Wellington Management 9.34M $741.64M +3.7%
STT State Street 9.25M $735.01M -1.0%
RY Royal Bank Of Canada 7.68M $610.16M +117.4%
Renaissance Technologies 4.7M $373.09M +2.3%
TROW T. Rowe Price 4.69M $372.66M -35.5%
Largest transactions Shares Bought/sold Change
RY Royal Bank Of Canada 7.68M +4.15M +117.4%
Capital International Investors 1.4M -2.66M -65.6%
TROW T. Rowe Price 4.69M -2.58M -35.5%
Baker Bros. Advisors 36.15M +2.54M +7.5%
UBS UBS Group AG - Registered Shares 2.94M +1.97M +204.8%
Norges Bank 0 -1.68M EXIT
Dodge & Cox 18.06M +1.4M +8.4%
Millennium Management 511.35K -1.27M -71.4%
Adage Capital Partners GP, L.L.C. 1.59M +1.1M +221.7%
Ubs Global Asset Management Americas 2.3M +966.25K +72.2%

Financial report summary

?
Management Discussion
  • We recorded net income of $38.0 million and basic and diluted net income per share of $0.17 for the three months ended March 31, 2022, as compared to net income of $53.5 million and basic and diluted net income per share of $0.24 in the corresponding period in 2021.  

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
New words: addressing, amplified, boxed, broader, Canadian, Carlo, certificate, chemical, confirmatory, crisaborole, Cyclin, defective, diagnostic, digit, dupilimab, DUPIXENT, eczema, enterprise, EUCRISA, forward, geopolitical, GMP, highlighted, idiopathic, instability, macroeconomic, merit, Monte, Montreal, MZL, neuropathy, NHL, NMPA, occupancy, Pfizer, phototherapy, prednisone, pulmonary, qualification, Regeneron, replication, resource, resourced, retaliatory, roll, Russia, Russian, safer, Sanofi, serine, shift, shrinkage, simulation, SRI, steroid, threonine, Ukraine, visitor, vivo
Removed: absorb, accounted, aged, aging, agnostic, Aid, allocate, allocation, amortizable, amortize, amortized, analyzing, anniversary, Answer, approximate, approximation, assigned, ASU, attribution, attrition, Austrian, axial, bankruptcy, beginning, beneficiary, binary, borrowing, BRAVE, call, Celgene, channel, characteristic, classification, classify, clearance, closely, coincide, collateral, collectability, collected, combined, comparing, conclude, constrain, constrained, constraint, context, controlling, converted, coordinate, counterparty, CRO, custodial, deduct, deducted, depreciation, determinable, dictated, directing, discretion, dispensing, distinct, dividing, dollar, elapsed, eligibility, entirety, environment, examination, expensed, facilitate, feasible, fedratinib, finite, fiscal, fixed, fleet, function, functionality, German, governance, granting, guaranteed, identification, immaterial, inception, inclusion, INREBIC, intangible, Internet, invoiced, judged, judgement, largest, lessee, magnitude, marketability, measuring, mentioned, methodological, methodology, modification, monitored, Motion, mutually, noncurrent, nonrefundable, outset, outsourced, participant, participatory, partnership, payable, payroll, performed, performing, periodically, Pocket, point, predominant, prepaid, prepare, prepay, prepayment, priced, print, printing, professional, progression, protective, prudent, psoriatic, quantitative, radio, realization, recognizing, recoverability, redemption, reliable, relief, renamed, reportable, reputable, residual, Restated, restrictive, retail, reversal, revert, reverting, reviewed, revised, Rodino, rollforward, running, satisfied, sector, secure, setup, shelf, sheltered, shipping, Simplifying, spending, Squibb, standalone, stimulate, subordinated, substantive, taxable, technical, television, thereon, Topic, transferred, transferring, translated, translating, trillion, TrOOP, true, uncured, undiscounted, unpaid, unusual, valid, variable, VIE, voting, waiting, waived, weighting, writing, written